INTRODUCTION Pancreatic ductal adenocarcinoma (PDA) is the fourth most common
cause of death from cancer worldwide and has a 5-year survival rate of 6%. Patients who …

Mortality remains alarmingly high for patients diagnosed with pancreatic ductal
adenocarcinoma (PDAC), with 93% succumbing to the disease within five years. The vast …

Recently, increasing evidence has indicated that the presence of tumor infiltrating immune
cells has shown predictive significance for many solid tumors. Present study was performed …

Pancreatic cancer is one of deadly cancers and is responsible for significant mortality and
morbidity across the globe. The unavailability of the efficient chemotheruptic drugs and the …

Objectives Pancreatic cancer has a lower morbidity yet higher case fatality rates (CFRs)
compared with other gastrointestinal cancers. The effects of socio-economic components on …

Purpose/aim: To focus on current molecular and genetic aspects and MTA proteins, since
pancreatic cancer is a lethal malignant with poor prognosis. Early diagnosis is essential …

Background Pancreatic cancer causes tremendous mortality across the globe mainly due to
late diagnosis and unavailability of efficient chemotheruptic agents. In the current study the …

High frequency of mortality in patients with pancreatic ductal adenocarcinoma (PDAC) is
vastly associated with the invasive and metastatic nature of these cancer cells. Little is …

Compared to single gemcitabine treatment, the combination of gemcitabine and erlotinib
has shown effective response in patients with locally advanced or metastatic pancreatic …

Background The link between age specific-rates of thyroid cancer (TC) and human
development index (HDI) and also its components can be a new direction for planning by …